• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.69% Nasdaq Up 0.44%

    Northwest Biotherapeutics, Inc. (NWBO)

    -NasdaqCM
    11.50 Down 0.50(4.17%) 4:00PM EDT
    Add to Portfolio
    Prev Close:12.00
    Open:12.01
    Bid:11.00 x 500
    Ask:12.50 x 300
    1y Target Est:5.00
    Beta:1.58
    Next Earnings Date:N/A
    Day's Range:11.38 - 12.19
    52wk Range:3.79 - 12.55
    Volume:390,318
    Avg Vol (3m):636,408
    Market Cap:885.44M
    P/E (ttm):N/A
    EPS (ttm):-2.14
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    NWBODown 4.17%885.44M
    AGENDown 1.08%693.46M
    DNDN 0.00%0.00

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):559.87
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :N/A
    Quarterly EPS Est (Jun-14) :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Northwest Biotherapeutics, Inc., a biotechnology company, discovers and develops immunotherapy products to treat cancer in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback